Jung Hwa Park

Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment

Tae Heung Kang, Jung Hwa Park, Andrew Yang et al. · Nature Communications · 2020 · 90 citations · Full text

Medicine, Immunology, Oncology +15

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine

Hyun Jin Park, Gun-Young Jang, Young Seob Kim et al. · Journal for ImmunoTherapy of Cancer · 2019 · 46 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Annexin A5 Increases Survival in Murine Sepsis Model by Inhibiting HMGB1-Mediated Proinflammation and Coagulation

Jung Hwa Park, Jong‐Hwa Jang, Eun Jung Choi et al. · Molecular Medicine · 2016 · 35 citations · Full text

Veterinary Medicine, Immunology, Pharmacology +17

Repositioning of the antipsychotic drug TFP for sepsis treatment

Jung Hwa Park, Hyun Jin Park, Sung Eun Lee et al. · Journal of Molecular Medicine · 2019 · 24 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

A novel function of API5 (apoptosis inhibitor 5), TLR4-dependent activation of antigen presenting cells

Young Seob Kim, Hyun Jin Park, Jung Hwa Park et al. · OncoImmunology · 2018 · 20 citations · Full text

Medicine, Immunology, Oncology +17